Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
54.53
+0.18 (0.33%)
Feb 21, 2025, 4:00 PM EST - Market closed
Disc Medicine Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Disc Medicine stock have an average target of 74.4, with a low estimate of 40 and a high estimate of 118. The average target predicts an increase of 36.44% from the current stock price of 54.53.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Disc Medicine stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $90 → $94 | Strong Buy | Maintains | $90 → $94 | +72.38% | Jan 24, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $70 → $73 | Buy | Maintains | $70 → $73 | +33.87% | Jan 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $118 | Strong Buy | Reiterates | $118 | +116.39% | Jan 21, 2025 |
| Stifel | Stifel | Strong Buy Maintains $79 → $90 | Strong Buy | Maintains | $79 → $90 | +65.05% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $118 | Strong Buy | Reiterates | $118 | +116.39% | Dec 9, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.22
from -3.42
EPS Next Year
-5.12
from -4.22
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | 57.1M | |||
| Avg | n/a | n/a | 23.9M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -4.07 | -4.31 | -3.18 | |||
| Avg | -4.22 | -5.12 | -5.10 | |||
| Low | -4.37 | -6.04 | -7.54 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.